US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 36.250
  • +0.310+0.86%
Close Jul 24 16:00 ET
  • 36.090
  • -0.160-0.44%
Pre 08:49 ET
2.02BMarket Cap-17303P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Structure Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.57

+24.00%
Analyst Rating

Strong Buy

Jul 24, 2024

Structure Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Structure Therapeutics Earnings Reports

  • Structure Therapeutics | 10-Q: Quarterly report

    May 9 17:00 ET

  • Structure Therapeutics | 10-K: Annual report

    Mar 8 09:25 ET

  • Structure Therapeutics | 10-Q: Quarterly report

    Nov 17, 2023 16:55 ET

  • Structure Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Nov 17, 2023 16:51 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 24, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Weight Loss Drugs
    Weight Loss Drugs
    Intraday-1.18%